Portfolio company
Bridge BIO
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This biopharmaceutical company develops and provides medicines for patients with genetic diseases and cancers with clear genetic drivers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
GondolaBio
This biopharmaceutical company develops clinical-stage and preclinical medicinal therapeutics for patients living with rare genetic diseases.
Actio Biosciences
This biotechnology company develops small molecule medicines to treat rare genetic diseases and common conditions for patients with high unmet medical needs.
Brickell Bio
This pharmaceutical company develops prescription therapeutics for patients with autoimmune, inflammatory and debilitating skin diseases.
Stridebio
This company develops engineered viral vectors and gene therapies for patients with rare genetic diseases.
CrossBridge Bio
This company develops dual-payload antibody-drug conjugates to treat solid tumors for healthcare providers and pharmaceutical partners.
Edgewise
This biopharmaceutical company develops oral small molecule therapies to treat patients with rare skeletal and cardiac muscle diseases.
D3 Bio
This biotechnology company develops precision medicines and oncology therapeutics for patients with cancer and immunological conditions.
Code Bio
This company develops non-viral genetic medicine delivery platforms and therapies for patients with rare and prevalent genetic diseases.